Viking Therapeutics (VKTX) Tops Q3 EPS by 4c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight